PharVision Advisers’s Barings BDC BBDC Stock Holding History

PharVision Advisers’s Portfolio BBDC Stock Details BBDC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-11,991	Closed	-$105K	–	709
2025 Q3	$105K	Buy	+11,991	New	+$113K	0.06%	618

Other funds holding BBDC

Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return

PMG

Private Management Group Irvine, California $3.47B AUM 13.39% 1-Year Est. Return

Ares Management Los Angeles, California $1.52B AUM 12.97% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

CAM

Cresset Asset Management Chicago, Illinois $23.1B AUM 27.04% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Focus Partners Wealth Boston, Massachusetts $89.9B AUM 20.5% 1-Year Est. Return

DCP

Diameter Capital Partners New York $1.07B AUM 152.29% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

PharVision Advisers's BBDC Position: Q4 2025 in Review

PharVision Advisers sold out of Barings BDC (BBDC) in Q4 2025, closing a stake of 11,991 shares — an estimated $105K sold.

PharVision Advisers first reported a position in BBDC in Q3 2025 and held it in 1 quarter. The position peaked at $105K in Q3 2025. 218 funds tracked by Wall St. Rank hold BBDC as of Q4 2025.

PharVision Advisers reported no remaining Barings BDC position as of Q4 2025 after selling out during the quarter.
PharVision Advisers sold 11,991 Barings BDC shares in Q4 2025, an estimated $105K.
PharVision Advisers first reported a position in Barings BDC in Q3 2025 and held it in 1 quarter.
PharVision Advisers's Barings BDC position peaked at $105K in Q3 2025.
218 funds tracked by Wall St. Rank held Barings BDC as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.